Arrowhead Pharmaceuticals Inc.

(ARWR)

By |

Profile

Arrowhead Pharmaceuticals Inc is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company\'s drug candidate ARC-520 is designed to treat chronic hepatitis B infection.

Contact Information

Website: www.arrowheadpharma.com
Main Phone: +1 626 304-3400
Address: 225 South Lake Avenue
Address 2: Suite 1050
State: CA
City / Town: Pasedena
Country: USA
Postal Code: 91101

Issuer Information

Exchange: NGS
Employees: 104
NAICS: 541711
$ 1.42 ($ 0.02) (-1.39%)
Last Price 1.42 Change $ -0.02 Change % -1.39 Tick N/A
Bid 1.45 Bid Size 100.00 Ask 1.50 Ask Size 500.00
Open 1.40 High 1.45 Low 1.39 Prev Close 1.44
Last Trade Volume 2.4 mi 52 Wk Hi 8.22 52 Wk Low 1.32
Market Cap 86.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 60,750,327.00 EPS (TTM) -1.40 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 16
Number of Buys 2 8
Number of Sells 1 8
Net Activity 8517 692350
Last 10 Buys Shares
Christopher Anzalone 1,000
Christopher Anzalone 1,000
Mauro Ferrari 1,000
Mauro Ferrari 1,000
Christopher Anzalone 1,000
Kenneth Myszkowski 1,000
Christopher Anzalone 1,000
Last 10 Sell Shares
Kenneth Myszkowski 1,000
David L. Lewis 1,000
Charles P. McKenney 1,000
Kenneth Myszkowski 1,000
Charles P. McKenney 1,000
Edward W. Frykman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 5.5 4.75 4.75 5.5
Mean Target Price Estimate 11.38 11.19 11.19 10.75
Standard Deviation 4.11 4.47 4.47 3.9
Date of Most Recent Estimate 08/10/16 05/20/16 05/20/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.67 1.67 1.67